Please login to the form below

Not currently logged in
Email:
Password:

Mysimba

This page shows the latest Mysimba news and features for those working in and with pharma, biotech and healthcare.

Positive data in Saxenda diabetes prevention study

Positive data in Saxenda diabetes prevention study

None of these has made significant headway since their US launches, and of the three only Orexigen's drug (branded as  Mysimba) has been backed in Europe, with both Belviq and

Latest news

  • CHMP thumbs up for Novo's obesity drug Saxenda CHMP thumbs up for Novo's obesity drug Saxenda

    s drug under the Mysimba brand name last December.  . ... The latest development means European doctors could have three drugs at their disposal to manage obesity patients in the coming months, with Saxenda and Mysimba slotting into the market alongside

  • Orexigen’s obesity pill Mysimba set for European approval Orexigen’s obesity pill Mysimba set for European approval

    The CHMP has recommended a marketing authorisation for Mysimba (naltrexone/bupropion) for weight management of overweight or obese adults. ... Across these studies, more patients treated with Mysimba achieved clinically-relevant weight loss than patients

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health is an integrated communications agency designed for and inspired by the ever-changing face of healthcare. In London, we...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics